Hyderabad, May 21 -- Aurobindo Pharma Limited on Thursday reported a consolidated net profit of Rs.921 crore for the fourth quarter ended March 31, 2026, registering a 2 per cent increase compared to Rs.903 crore reported in the corresponding quarter of the previous financial year.
The Hyderabad-based pharmaceutical major reported revenue from operations of Rs.8,853 crore during the quarter, up 5.6 per cent year-on-year from Rs.8,382 crore.
For the full financial year FY26, the company's revenue from operations rose 6.1 per cent to Rs.33,653 crore, the pharma company said in a release.
EBITDA before forex and other income stood at Rs.1,801 crore for the quarter, while EBITDA margin was reported at 20.3 per cent.
The company said its Eur...